INOVIO PHARMACEUTICALS, INC. (INO) › Operating IncomeINOVIO PHARMACEUTICALS, INC. (INO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$13.96M2010: -$19.22M2011: -$21.64M2012: -$23.49M2013: -$19.54M2014: -$39.50M2015: -$34.28M2016: -$76.24M2017: -$83.64M2018: -$94.09M2019: -$111.11M2020: -$124.08M2021: -$301.22M2022: -$267.57M2023: -$143.94M2024: -$112.40M2025: -$86.82M-$86.82M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$86.82M+22.8%2024-$112.40M+21.9%2023-$143.94M+46.2%2022-$267.57M+11.2%2021-$301.22M-142.8%2020-$124.08M-11.7%2019-$111.11M-18.1%2018-$94.09M-12.5%2017-$83.64M-9.7%2016-$76.24M-122.4%2015-$34.28M+13.2%2014-$39.50M-102.1%2013-$19.54M+16.8%2012-$23.49M-8.6%2011-$21.64M-12.6%2010-$19.22M-37.7%2009-$13.96M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share